摘要
目的探讨莫西沙星注射液致低血钾的机制,为临床安全合理使用莫西沙星提供参考。方法分析该患者接受莫西沙星注射液治疗后发生低血钾的诊疗过程。结果患者静脉滴注莫西沙星注射液1周后出现低血钾(2.78 mmol·L^(-1)),予停用莫西沙星注射液,静脉及口服补钾后,血钾恢复(4.41 mmol·L^(-1))。结论静脉滴注莫西沙星注射液可能导致低血钾,治疗中应予以重视。
Objective To explore the mechanism by which hypokalemia is caused by moxifloxacin injection so as to provide reference for clinical rational and safe use of moxifloxacin.Methods The diagnosis and treatment process of one case of hypokalemia after moxifloxacin injection was analyzed.Results Symptoms of hypokalemia(2.78 mmol·L^(-1))occurred one week after intravenous injection of moxifloxacin.After moxifloxacin injection was withdrawn and intravenous and oral potassium supplementation was started,the level of potassium returned to normal(4.41 mmol·L^(-1)).Conclusion Intravenous injection of moxifloxacin may lead to hypokalemia,which deserves more attention in clinic.
作者
杨桂玲
赵牡丹
高义玲
王贝
朱明辉
YANG Guiling;ZHAO Mudan;GAO Yiling;WANG Bei;ZHU Minghui(The Affiliated Nanjing Tongren Hospital of Southeast University Medical College,Nanjing Jiangsu 211102,China)
出处
《中国药物警戒》
2022年第3期342-344,共3页
Chinese Journal of Pharmacovigilance